NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|208610002|ref|NP_001129145|]
View 

atlastin-2 isoform 2 [Homo sapiens]

Protein Classification

atlastin( domain architecture ID 10491594)

membrane-anchored GTPase atlastin couples nucleotide hydrolysis to the catalysis of homotypic membrane fusion to form a branched endoplasmic reticulum network; functions in endoplasmic reticulum tubular network biogenesis; most closely related to the guanylate-binding protein (GBP)subfamily

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
GBP pfam02263
Guanylate-binding protein, N-terminal domain; Transcription of the anti-viral ...
70-341 4.53e-130

Guanylate-binding protein, N-terminal domain; Transcription of the anti-viral guanylate-binding protein (GBP) is induced by interferon-gamma during macrophage induction. This family contains GBP1 and GPB2, both GTPases capable of binding GTP, GDP and GMP.


:

Pssm-ID: 460516  Cd Length: 260  Bit Score: 380.95  E-value: 4.53e-130
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 208610002   70 DHNFELDEEALEQIllqeHIRDLNIVVVSVAGAFRKGKSFLLDFMLRymynkdsqswiggnnePLTGFTWRGGCERETTG 149
Cdd:pfam02263   1 DHQLELNEEALEIL----SAITQPVVVVAIAGLYRTGKSFLMNFLAG----------------KLTGFSLGGTVESETKG 60
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 208610002  150 IQVWNEVfvidRPNGTKVAVLLMDTQGAFD-SQSTIKDCATVFALSTMTSSVQVYNLSQNIQEDDLQHLQLFTE------ 222
Cdd:pfam02263  61 IWMWCVP----HPNKPKHTLVLLDTEGLGDvEKSDNKNDAWIFALATLLSSTFVYNSSQTINQQALQQLHLVTEltelss 136
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 208610002  223 --YGRLAMEEIYQKPFQTLMFLIRDWSYPYEHSYGLEGGKQFLEKRLQVKQNQHEELQN---VRKHIHNCFSNLGCFLLP 297
Cdd:pfam02263 137 prYGRVADSADFVSFFPDFVWTVRDFSLPLEADGGPITGDEYLENRLKLSQGQHEELQNfnlPRLCIRSFFPKRKCFLFD 216
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|....*
gi 208610002  298 HPGLKVATNPSFDG-RLKDIDEDFKRELRNLVPLLLApENLVEKE 341
Cdd:pfam02263 217 RPGLKKALNPQFEGlREDELDPEFQQQLREFCSYILS-HSLVKTL 260
 
Name Accession Description Interval E-value
GBP pfam02263
Guanylate-binding protein, N-terminal domain; Transcription of the anti-viral ...
70-341 4.53e-130

Guanylate-binding protein, N-terminal domain; Transcription of the anti-viral guanylate-binding protein (GBP) is induced by interferon-gamma during macrophage induction. This family contains GBP1 and GPB2, both GTPases capable of binding GTP, GDP and GMP.


Pssm-ID: 460516  Cd Length: 260  Bit Score: 380.95  E-value: 4.53e-130
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 208610002   70 DHNFELDEEALEQIllqeHIRDLNIVVVSVAGAFRKGKSFLLDFMLRymynkdsqswiggnnePLTGFTWRGGCERETTG 149
Cdd:pfam02263   1 DHQLELNEEALEIL----SAITQPVVVVAIAGLYRTGKSFLMNFLAG----------------KLTGFSLGGTVESETKG 60
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 208610002  150 IQVWNEVfvidRPNGTKVAVLLMDTQGAFD-SQSTIKDCATVFALSTMTSSVQVYNLSQNIQEDDLQHLQLFTE------ 222
Cdd:pfam02263  61 IWMWCVP----HPNKPKHTLVLLDTEGLGDvEKSDNKNDAWIFALATLLSSTFVYNSSQTINQQALQQLHLVTEltelss 136
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 208610002  223 --YGRLAMEEIYQKPFQTLMFLIRDWSYPYEHSYGLEGGKQFLEKRLQVKQNQHEELQN---VRKHIHNCFSNLGCFLLP 297
Cdd:pfam02263 137 prYGRVADSADFVSFFPDFVWTVRDFSLPLEADGGPITGDEYLENRLKLSQGQHEELQNfnlPRLCIRSFFPKRKCFLFD 216
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|....*
gi 208610002  298 HPGLKVATNPSFDG-RLKDIDEDFKRELRNLVPLLLApENLVEKE 341
Cdd:pfam02263 217 RPGLKKALNPQFEGlREDELDPEFQQQLREFCSYILS-HSLVKTL 260
GBP cd01851
Guanylate-binding protein (GBP) family (N-terminal domain); Guanylate-binding protein (GBP), ...
90-334 4.97e-70

Guanylate-binding protein (GBP) family (N-terminal domain); Guanylate-binding protein (GBP), N-terminal domain. Guanylate-binding proteins (GBPs) define a group of proteins that are synthesized after activation of the cell by interferons. The biochemical properties of GBPs are clearly different from those of Ras-like and heterotrimeric GTP-binding proteins. They bind guanine nucleotides with low affinity (micromolar range), are stable in their absence and have a high turnover GTPase. In addition to binding GDP/GTP, they have the unique ability to bind GMP with equal affinity and hydrolyze GTP not only to GDP, but also to GMP. Furthermore, two unique regions around the base and the phosphate-binding areas, the guanine and the phosphate caps, respectively, give the nucleotide-binding site a unique appearance not found in the canonical GTP-binding proteins. The phosphate cap, which constitutes the region analogous to switch I, completely shields the phosphate-binding site from solvent such that a potential GTPase-activating protein (GAP) cannot approach.


Pssm-ID: 206650  Cd Length: 224  Bit Score: 225.28  E-value: 4.97e-70
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 208610002  90 RDLNIVVVSVAGAFRKGKSFLLDFMLRYMynkdsqswiggnneplTGFTWRGGCERETTGIQVWNEVFVIDrpNGTKVAV 169
Cdd:cd01851    3 VGFPVVVVSVFGSQSSGKSFLLNHLFGTS----------------DGFDVMDTSQQTTKGIWMWSDPFKDT--DGKKHAV 64
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 208610002 170 LLMDTQGAFDSQSTI-KDCATVFALSTMTSSVQVYNLSQNIQEDDLQHLQLFTE----YGRLAMEEIYQKPFQTLMFLIR 244
Cdd:cd01851   65 LLLDTEGTDGRERGEfENDARLFALATLLSSVLIYNMWQTILGDDLDKLMGLLKtaleTLGLAGLHNFSKPKPLLLFVVR 144
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 208610002 245 DWSYPYEHSYGLEGgkqflekrlQVKQNQHEELQNVRKHIHNCFSNLGCFLLPHPGLKVATNPSfDGRLKDIDEDFKREL 324
Cdd:cd01851  145 DFTGPTPLEGLDVT---------EKSETLIEELNKIWSSIRKPFTPITCFVLPHPGLLHKLLQN-DGRLKDLPPEFRKAL 214
                        250
                 ....*....|
gi 208610002 325 RNLVPLLLAP 334
Cdd:cd01851  215 KALRQRFFSS 224
 
Name Accession Description Interval E-value
GBP pfam02263
Guanylate-binding protein, N-terminal domain; Transcription of the anti-viral ...
70-341 4.53e-130

Guanylate-binding protein, N-terminal domain; Transcription of the anti-viral guanylate-binding protein (GBP) is induced by interferon-gamma during macrophage induction. This family contains GBP1 and GPB2, both GTPases capable of binding GTP, GDP and GMP.


Pssm-ID: 460516  Cd Length: 260  Bit Score: 380.95  E-value: 4.53e-130
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 208610002   70 DHNFELDEEALEQIllqeHIRDLNIVVVSVAGAFRKGKSFLLDFMLRymynkdsqswiggnnePLTGFTWRGGCERETTG 149
Cdd:pfam02263   1 DHQLELNEEALEIL----SAITQPVVVVAIAGLYRTGKSFLMNFLAG----------------KLTGFSLGGTVESETKG 60
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 208610002  150 IQVWNEVfvidRPNGTKVAVLLMDTQGAFD-SQSTIKDCATVFALSTMTSSVQVYNLSQNIQEDDLQHLQLFTE------ 222
Cdd:pfam02263  61 IWMWCVP----HPNKPKHTLVLLDTEGLGDvEKSDNKNDAWIFALATLLSSTFVYNSSQTINQQALQQLHLVTEltelss 136
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 208610002  223 --YGRLAMEEIYQKPFQTLMFLIRDWSYPYEHSYGLEGGKQFLEKRLQVKQNQHEELQN---VRKHIHNCFSNLGCFLLP 297
Cdd:pfam02263 137 prYGRVADSADFVSFFPDFVWTVRDFSLPLEADGGPITGDEYLENRLKLSQGQHEELQNfnlPRLCIRSFFPKRKCFLFD 216
                         250       260       270       280
                  ....*....|....*....|....*....|....*....|....*
gi 208610002  298 HPGLKVATNPSFDG-RLKDIDEDFKRELRNLVPLLLApENLVEKE 341
Cdd:pfam02263 217 RPGLKKALNPQFEGlREDELDPEFQQQLREFCSYILS-HSLVKTL 260
GBP cd01851
Guanylate-binding protein (GBP) family (N-terminal domain); Guanylate-binding protein (GBP), ...
90-334 4.97e-70

Guanylate-binding protein (GBP) family (N-terminal domain); Guanylate-binding protein (GBP), N-terminal domain. Guanylate-binding proteins (GBPs) define a group of proteins that are synthesized after activation of the cell by interferons. The biochemical properties of GBPs are clearly different from those of Ras-like and heterotrimeric GTP-binding proteins. They bind guanine nucleotides with low affinity (micromolar range), are stable in their absence and have a high turnover GTPase. In addition to binding GDP/GTP, they have the unique ability to bind GMP with equal affinity and hydrolyze GTP not only to GDP, but also to GMP. Furthermore, two unique regions around the base and the phosphate-binding areas, the guanine and the phosphate caps, respectively, give the nucleotide-binding site a unique appearance not found in the canonical GTP-binding proteins. The phosphate cap, which constitutes the region analogous to switch I, completely shields the phosphate-binding site from solvent such that a potential GTPase-activating protein (GAP) cannot approach.


Pssm-ID: 206650  Cd Length: 224  Bit Score: 225.28  E-value: 4.97e-70
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 208610002  90 RDLNIVVVSVAGAFRKGKSFLLDFMLRYMynkdsqswiggnneplTGFTWRGGCERETTGIQVWNEVFVIDrpNGTKVAV 169
Cdd:cd01851    3 VGFPVVVVSVFGSQSSGKSFLLNHLFGTS----------------DGFDVMDTSQQTTKGIWMWSDPFKDT--DGKKHAV 64
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 208610002 170 LLMDTQGAFDSQSTI-KDCATVFALSTMTSSVQVYNLSQNIQEDDLQHLQLFTE----YGRLAMEEIYQKPFQTLMFLIR 244
Cdd:cd01851   65 LLLDTEGTDGRERGEfENDARLFALATLLSSVLIYNMWQTILGDDLDKLMGLLKtaleTLGLAGLHNFSKPKPLLLFVVR 144
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 208610002 245 DWSYPYEHSYGLEGgkqflekrlQVKQNQHEELQNVRKHIHNCFSNLGCFLLPHPGLKVATNPSfDGRLKDIDEDFKREL 324
Cdd:cd01851  145 DFTGPTPLEGLDVT---------EKSETLIEELNKIWSSIRKPFTPITCFVLPHPGLLHKLLQN-DGRLKDLPPEFRKAL 214
                        250
                 ....*....|
gi 208610002 325 RNLVPLLLAP 334
Cdd:cd01851  215 KALRQRFFSS 224
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH